MedTrace Logo

Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures

NCT04797897 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2025-03-25

Study results available
· View outcomes & findings →

Summary

This is a prospective study to demonstrate the safety and effectiveness of CORI and to register CORI in China mainland.

Conditions

  • Non-inflammatory Degenerative Joint Disease
  • Osteoarthritis
  • Avascular Necrosis
  • Requires Correction of Functional Deformity
  • Fracture, Knee

Interventions

DEVICE

CORI

unicondylar knee arthroplasty (UKA) treated with CORI

DEVICE

Conventional

unicondylar knee arthroplasty (UKA) treated with conventional approach with conventional manual instrumentation

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Patricia McCracken · Smith & Nephew, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-12
Primary Completion
2023-09-29
Completion
2024-02-16
FDA Device
Yes

Countries

  • Australia
  • Hong Kong
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04797897 on ClinicalTrials.gov